Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Locke

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|August 27, 2014
Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance geneJeffrey B Locke, Douglas E Zuill, Caitlyn R Scharn, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2014
Identification and characterization of linezolid-resistant cfr-positive Staphylococcus aureus USA300 isolates from a New York City medical centerJeffrey B Locke, Douglas E Zuill, Caitlyn R Scharn, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutationsJeffrey B Locke, John Finn, Mark Hilgers, et al.
Journal of Fungi (Basel, Switzerland)|September 27, 2024
In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four <i>Candida auris</i> Clades in a Neutropenic Mouse Bloodstream Infection ModelDávid Balázsi, Zoltán Tóth, Jeffrey B Locke, et al.
Cell Host & Microbe|August 12, 2008
The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killingAnnelies S Zinkernagel, Anjuli M Timmer, Morgan A Pence, et al.
American Journal of Lifestyle Medicine|July 8, 2026
The Impacts of a Primary Care-Based Dietitian Health Coaching Intervention on Patients' Health: An Observational StudyAmy B Locke, Brittany L Sisco-Taylor, Xuechen Wang, et al.
International Forum of Allergy & Rhinology|June 20, 2020
Complete endoscopic sinus surgery followed by aspirin desensitization is associated with decreased overall corticosteroid useJohn V Bosso, Tran B Locke, Edward C Kuan, et al.
Journal of Medicinal Chemistry|February 1, 2013
Identification of bacteria-selective threonyl-tRNA synthetase substrate inhibitors by structure-based designMin Teng, Mark T Hilgers, Mark L Cunningham, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2024
Outcomes by <i>Candida</i> spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasisJeffrey B Locke, Chris M Pillar, Mariana Castanheira, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 24, 2024
Clinical and mycological outcomes of candidaemia and/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofunginAlex Soriano, Jeffrey B Locke, Oliver A Cornely, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|August 27, 2014
Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance geneJeffrey B Locke, Douglas E Zuill, Caitlyn R Scharn, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2014
Identification and characterization of linezolid-resistant cfr-positive Staphylococcus aureus USA300 isolates from a New York City medical centerJeffrey B Locke, Douglas E Zuill, Caitlyn R Scharn, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutationsJeffrey B Locke, John Finn, Mark Hilgers, et al.
Journal of Fungi (Basel, Switzerland)|September 27, 2024
In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four <i>Candida auris</i> Clades in a Neutropenic Mouse Bloodstream Infection ModelDávid Balázsi, Zoltán Tóth, Jeffrey B Locke, et al.
Cell Host & Microbe|August 12, 2008
The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neutrophil killingAnnelies S Zinkernagel, Anjuli M Timmer, Morgan A Pence, et al.
American Journal of Lifestyle Medicine|July 8, 2026
The Impacts of a Primary Care-Based Dietitian Health Coaching Intervention on Patients' Health: An Observational StudyAmy B Locke, Brittany L Sisco-Taylor, Xuechen Wang, et al.
International Forum of Allergy & Rhinology|June 20, 2020
Complete endoscopic sinus surgery followed by aspirin desensitization is associated with decreased overall corticosteroid useJohn V Bosso, Tran B Locke, Edward C Kuan, et al.
Journal of Medicinal Chemistry|February 1, 2013
Identification of bacteria-selective threonyl-tRNA synthetase substrate inhibitors by structure-based designMin Teng, Mark T Hilgers, Mark L Cunningham, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2024
Outcomes by <i>Candida</i> spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasisJeffrey B Locke, Chris M Pillar, Mariana Castanheira, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 24, 2024
Clinical and mycological outcomes of candidaemia and/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofunginAlex Soriano, Jeffrey B Locke, Oliver A Cornely, et al.
Pageof 12